Clene submits NDA for ALS treatment candidate.
Clene Inc. filed a New Drug Application with the FDA seeking accelerated approval of CNM-Au8 for ALS, a significant regulatory milestone for the company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed